Utah Peaks Capital’s Thermo Fisher Scientific TMO Stock Holding History

Utah Peaks Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,030	Closed	-$567K	–	72
2022 Q4	$567K	Buy	+1,030	New	+$546K	1.03%	14

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Utah Peaks Capital's TMO Position: Q1 2023 in Review

Utah Peaks Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 1,030 shares — an estimated $567K sold.

Utah Peaks Capital first reported a position in TMO in Q4 2022 and held it in 1 quarter. The position peaked at $567K in Q4 2022. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

Utah Peaks Capital reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
Utah Peaks Capital sold 1,030 Thermo Fisher Scientific shares in Q1 2023, an estimated $567K.
Utah Peaks Capital first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 1 quarter.
Utah Peaks Capital's Thermo Fisher Scientific position peaked at $567K in Q4 2022.
2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Utah Peaks Capital's 13F filing for Q1 2023, filed 15 May 2023.